Black mat syndrome is a progressive shell disease affecting marine crustaceans, characterized by dark melanized lesions that develop on the exoskeleton and can penetrate into underlying tissues. The condition results from bacterial infection of the chitinous exoskeleton, typically beginning at sites of damage, stress, or environmental compromise. As the bacteria digest chitin, the primary structural component of the exoskeleton, the crustacean's immune system responds by depositing melanin at the infection sites, creating the characteristic black discoloration that gives the syndrome its name. Without intervention, the disease can spread across the shell surface and eventually penetrate to internal tissues.
Marine crustaceans of many types are susceptible to black mat syndrome, including crabs of various species, lobsters, and shrimp. The condition is seen in both wild populations and captive marine aquarium specimens, though it manifests somewhat differently in each context. In aquarium settings, the disease typically indicates water quality problems or environmental stress that have compromised the exoskeleton's natural defenses against bacterial colonization. Understanding that black mat syndrome is fundamentally an environmental disease is essential for both treatment and prevention.
The impact of black mat syndrome on crustacean health ranges from minor cosmetic damage to life-threatening systemic infection depending on the extent and location of lesions. Early-stage disease limited to the outer exoskeleton may cause little functional impairment and can resolve with the next molt if conditions improve. However, lesions affecting joint membranes, gills, or other critical areas can impair mobility, respiration, and other vital functions. Deep infections that penetrate through the exoskeleton allow bacterial invasion of internal tissues with potentially fatal consequences. The progressive nature of the disease means that early intervention offers the best prognosis.
Treatability of black mat syndrome depends primarily on the stage at which it is addressed and the underlying causes. Early-stage lesions limited to the exoskeleton surface can often resolve completely after the next molt, provided that environmental conditions are corrected and the crustacean's health is otherwise supported. Advanced disease with deep tissue involvement is much more difficult to manage and may not respond to environmental correction alone. Because copper-based medications are lethal to crustaceans and most other aquarium medications are untested or unsafe for invertebrates, treatment focuses on environmental optimization rather than pharmaceutical intervention. Prognosis is good for mild cases caught early and poor for advanced infections.
